Novel Therapeutic Vulnerabilities in Cervical Neuroendocrine Carcinoma
Haider S. Mahdi, MD
Active Projects
Optimizing chelator compositions for alpha particle-based PRRT in neuroendocrine tumors
Dongyoul Lee, PhD
PANNET Modeling, Mechanisms, and Experimental Treatment
James Bibb, PhD
PRESCIENT – PET ResponSe CrItEria for Neuroendocrine Tumors
Lisa Bodei, MD, PhD
Radiosensitizing NETs: a two-pronged approach using ERa and Pin1 inhibition
Xavier M. Keutgen, MD
Reconciling lung carcinoids histopathological and molecular classifications
Matthieu Foll, PhD
Reconstructing the evolutionary history of neuroendocrine tumor subtypes
Nicolas Alcala, PhD
Role of Nrf2 in SBNET drug resistance and development of a novel inhibitor
Po Hien Ear, PhD
Role of the peripheral nervous system in pancreatic neuroendocrine tumors
William Hwang, MD, PhD
Single-Cell Proteomics of Pancreatic Neuroendocrine Tumors
Michael H. Roehrl, MD, PhD